Technical Analysis for SPRB - Spruce Biosciences, Inc.

Grade Last Price % Change Price Change
F 23.42 -1.14% -0.27
SPRB closed down 1.14 percent on Friday, January 15, 2021, on 32 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Flat Up
Historical SPRB trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
20 DMA Support Bullish 0.00%
Inside Day Range Contraction 0.00%
20 DMA Support Bullish -1.14%
Crossed Above 50 DMA Bullish -1.14%
MACD Bullish Signal Line Cross Bullish -1.14%
Up 3 Days in a Row Strength -1.14%
50 DMA Resistance Bearish 1.96%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.96%
Older End-of-Day Signals for SPRB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy, which is in Phase IIb clinical trial for adult patients with classic congenital adrenal hyperplasia (CAH) and in Phase II clinical trial in children with classic CAH. It is also developing tildacerfont for females with polycystic ovary syndrome. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was founded in 2014 and is headquartered in Daly City, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Anatomy Hyperplasia Cah Endocrine Disorders Adrenal Gland Disorders Congenital Adrenal Hyperplasia Classic Congenital Adrenal Hyperplasia Neurocrine Biosciences

Is SPRB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 35.6
52 Week Low 15.14
Average Volume 89,896
200-Day Moving Average 0.00
50-Day Moving Average 23.47
20-Day Moving Average 22.65
10-Day Moving Average 22.19
Average True Range 2.02
ADX 16.15
+DI 16.90
-DI 20.00
Chandelier Exit (Long, 3 ATRs ) 19.31
Chandelier Exit (Short, 3 ATRs ) 25.80
Upper Bollinger Band 25.22
Lower Bollinger Band 20.08
Percent B (%b) 0.65
BandWidth 22.66
MACD Line -0.18
MACD Signal Line -0.29
MACD Histogram 0.1079
Fundamentals Value
Market Cap 543.67 Million
Num Shares 23.2 Million
EPS
Price-to-Sales 0.00
Price-to-Book 21.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.45
Resistance 3 (R3) 25.40 24.69 25.11
Resistance 2 (R2) 24.69 24.17 24.71 24.99
Resistance 1 (R1) 24.05 23.85 23.70 24.10 24.88
Pivot Point 23.34 23.34 23.16 23.36 23.34
Support 1 (S1) 22.70 22.82 22.35 22.75 21.96
Support 2 (S2) 21.99 22.50 22.01 21.85
Support 3 (S3) 21.35 21.99 21.73
Support 4 (S4) 21.40